Literature DB >> 30090985

Morvan's syndrome-is a pathogen behind the curtain?

Rohit Singh1, Pritam Das1, Upinder Kaur2, Anamika Misra3, Ashis Choudhury1, Sukdev Manna1, Rohit Gaude1, Deepak Gautam1, Indrajeet Singh Gambhir4, Sankha Shubhra Chakrabarti5.   

Abstract

Morvan's syndrome is a rare syndrome of likely autoimmune etiology characterized by peripheral nerve hyperexcitability, dysautonomia, insomnia, and fluctuating delirium with prominent hallucinations. Since its first mention in 1890, less than 100 cases have been described in literature. The largest existing review includes details of 29 cases. This case series describes 4 cases (M = 4) of Morvan's syndrome which presented between May and November 2017 to a single tertiary care referral teaching hospital in north India. All the four patients manifested behavioral abnormalities, sleep disturbances, hallucinations, autonomic dysfunction, and clinical signs of peripheral nerve hyperexcitability, mostly as myokymia. Two of the patients had Anti-CASPR2 (contactin-associated protein 2) antibodies. Three of them had electromyography features of peripheral nerve hyperexcitability and only one had elevated cerebrospinal fluid protein level. We hypothesize that Morvan's syndrome and other less characterized autoimmune encephalitis/peripheral nervous system syndromes may have infectious triggers. A possible viral trigger may result in generation of autoantibodies which result in the typical manifestations. We base these hypotheses on the finding of four cases of an orphan disease within a short period of time in a limited geographical distribution.

Entities:  

Keywords:  Morvan’s syndrome; Myokymia; Neuromyotonia; Pathogenesis; VGKC (voltage-gated potassium channel); Viral

Mesh:

Substances:

Year:  2018        PMID: 30090985     DOI: 10.1007/s10072-018-3515-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  18 in total

Review 1.  Diagnosis and treatment of viral encephalitis.

Authors:  A Chaudhuri; P G E Kennedy
Journal:  Postgrad Med J       Date:  2002-10       Impact factor: 2.401

Review 2.  [Anti-VGKC antibody-associated limbic encephalitis/Morvan syndrome].

Authors:  Tamako Misawa; Hidehiro Mizusawa
Journal:  Brain Nerve       Date:  2010-04

3.  Ureaplasma urealyticum and Mycoplasma hominis in women with systemic lupus erythematosus.

Authors:  K S Ginsburg; R B Kundsin; C W Walter; P H Schur
Journal:  Arthritis Rheum       Date:  1992-04

4.  Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity-syndrome of parkinsonism and ataxia.

Authors:  Sudheeran Kannoth; Vivek Nambiar; Siby Gopinath; Anandkumar Anandakuttan; Annamma Mathai; Parvathy Kanjiramana Rajan
Journal:  Neurol Sci       Date:  2017-12-20       Impact factor: 3.307

5.  Augustin Morvan (1819-1897), a little-known rural physician and neurologist.

Authors:  O Walusinski; J Honnorat
Journal:  Rev Neurol (Paris)       Date:  2012-07-02       Impact factor: 2.607

Review 6.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

7.  Morvan Syndrome: A Case Report With Patient Narrative and Video.

Authors:  Mark Maskery; Suresh K Chhetri; Rejith Dayanandan; Claire Gall; Hedley C A Emsley
Journal:  Neurohospitalist       Date:  2016-01

8.  Aseptic central nervous system infections in adults: what predictor for unknown etiological diagnosis?

Authors:  Jacopo Monticelli; Nicholas Geremia; Pierlanfranco D'Agaro; Vincenzo Petix; Roberto Luzzati
Journal:  Neurol Sci       Date:  2018-02-17       Impact factor: 3.307

9.  Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.

Authors:  Sarosh R Irani; Sian Alexander; Patrick Waters; Kleopas A Kleopa; Philippa Pettingill; Luigi Zuliani; Elior Peles; Camilla Buckley; Bethan Lang; Angela Vincent
Journal:  Brain       Date:  2010-07-27       Impact factor: 13.501

Review 10.  The Diagnosis and Treatment of Autoimmune Encephalitis.

Authors:  Eric Lancaster
Journal:  J Clin Neurol       Date:  2016-01       Impact factor: 3.077

View more
  4 in total

1.  Morvan's syndrome treated successfully with rituximab and lacosamide.

Authors:  Olafur Sveinsson; Faiez Al Nimer; Fredrik Piehl
Journal:  BMJ Case Rep       Date:  2019-02-13

2.  CASPR2-Related Morvan Syndrome: Autonomic, Polysomnographic, and Neuropsychological Observations.

Authors:  Panda Sudha Swayang; Atchayaram Nalini; Veeramani Preethish-Kumar; Kaviraja Udupa; Ravi Yadav; Seena Vengalil; Sheikh Sultana Reshma; Kiran Polavarapu; Saraswati Nashi; T N Sathyaprabha; Priya Treesa Thomas; Bhat Maya; Rajeshwaran Jamuna; Anita Mahadevan; M Netravathi
Journal:  Neurol Clin Pract       Date:  2021-06

3.  COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?

Authors:  Sankha Shubhra Chakrabarti; Upinder Kaur; Anindita Banerjee; Upasana Ganguly; Tuhina Banerjee; Sarama Saha; Gaurav Parashar; Suvarna Prasad; Suddhachitta Chakrabarti; Amit Mittal; Bimal Kumar Agrawal; Ravindra Kumar Rawal; Robert Chunhua Zhao; Indrajeet Singh Gambhir; Rahul Khanna; Ashok K Shetty; Kunlin Jin; Sasanka Chakrabarti
Journal:  Aging Dis       Date:  2020-05-09       Impact factor: 6.745

4.  Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 Antibodies.

Authors:  Maurizio Benucci; Luciana Tramacere; Maria Infantino; Mariangela Manfredi; Valentina Grossi; Arianna Damiani; Francesca Li Gobbi; Maristella Piccininni; Gaetano Zaccara; Massimo Cincotta
Journal:  Case Rep Neurol Med       Date:  2020-02-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.